a multicentre , non-comparative study was performed to evaluate the clinical efficacy and safety of imipenem/cilastatin given iv to 53 seriously ill patients with severe bacterial infections , including 16 episodes of uti , 12 pleuropulmonary , eight intra-abdominal , seven osteoarticular , and two soft tissue infections , three episodes of catheter related sepsis , two primary bacteraemias , one case of endocarditis , one of endophthalmitis , and one of disseminated gonococcal infection .
C0004623
bacterial infections
C0004610
bacteraemias